← 產業報告目錄
Peramivir Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-02頁數 122報告編號 APO-fed93785ef
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Peramivir market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Peramivir is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Peramivir is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Peramivir is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Peramivir include BioCryst Pharmaceuticals, Green Cross Pharma, Hikma Pharmaceuticals, Moksha8 Pharma, NeoPharm, NT Pharma, SCOLR Pharma, Hunan Nucien Pharmaceutical Co., Ltd. and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Peramivir market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Peramivir Market by Company
BioCryst Pharmaceuticals
Green Cross Pharma
Hikma Pharmaceuticals
Moksha8 Pharma
NeoPharm
NT Pharma
SCOLR Pharma
Hunan Nucien Pharmaceutical Co., Ltd.
Merck
Shionogi Co.
Peramivir Segment by Type
Solution
Solid
Peramivir Segment by Application
Influenza A Treatment
Influenza B Treatment
Peramivir Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peramivir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Peramivir and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peramivir.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Peramivir manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Peramivir by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Peramivir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Peramivir Market Size (2021-2032)
2.2.2 Global Peramivir Sales (2021-2032)
2.2.3 Global Peramivir Market Average Price (2021-2032)
2.3 Peramivir by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Solution
2.3.3 Solid
2.4 Peramivir by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Influenza A Treatment
2.4.3 Influenza B Treatment
3 Market Competitive Landscape by Manufacturers
3.1 Global Peramivir Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Peramivir Sales (Tons) of Manufacturers (2021-2026)
3.3 Global Peramivir Revenue of Manufacturers (2021-2026)
3.4 Global Peramivir Average Price by Manufacturers (2021-2026)
3.5 Global Peramivir Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Peramivir, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Peramivir, Product Type & Application
3.8 Global Manufacturers of Peramivir, Established Date
3.9 Global Peramivir Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 BioCryst Pharmaceuticals
4.1.1 BioCryst Pharmaceuticals Company Information
4.1.2 BioCryst Pharmaceuticals Business Overview
4.1.3 BioCryst Pharmaceuticals Peramivir Sales, Revenue and Gross Margin (2021-2026)
4.1.4 BioCryst Pharmaceuticals Peramivir Product Portfolio
4.1.5 BioCryst Pharmaceuticals Recent Developments
4.2 Green Cross Pharma
4.2.1 Green Cross Pharma Company Information
4.2.2 Green Cross Pharma Business Overview
4.2.3 Green Cross Pharma Peramivir Sales, Revenue and Gross Margin (2021-2026)
4.2.4 Green Cross Pharma Peramivir Product Portfolio
4.2.5 Green Cross Pharma Recent Developments
4.3 Hikma Pharmaceuticals
4.3.1 Hikma Pharmaceuticals Company Information
4.3.2 Hikma Pharmaceuticals Business Overview
4.3.3 Hikma Pharmaceuticals Peramivir Sales, Revenue and Gross Margin (2021-2026)
4.3.4 Hikma Pharmaceuticals Peramivir Product Portfolio
4.3.5 Hikma Pharmaceuticals Recent Developments
4.4 Moksha8 Pharma
4.4.1 Moksha8 Pharma Company Information
4.4.2 Moksha8 Pharma Business Overview
4.4.3 Moksha8 Pharma Peramivir Sales, Revenue and Gross Margin (2021-2026)
4.4.4 Moksha8 Pharma Peramivir Product Portfolio
4.4.5 Moksha8 Pharma Recent Developments
4.5 NeoPharm
4.5.1 NeoPharm Company Information
4.5.2 NeoPharm Business Overview
4.5.3 NeoPharm Peramivir Sales, Revenue and Gross Margin (2021-2026)
4.5.4 NeoPharm Peramivir Product Portfolio
4.5.5 NeoPharm Recent Developments
4.6 NT Pharma
4.6.1 NT Pharma Company Information
4.6.2 NT Pharma Business Overview
4.6.3 NT Pharma Peramivir Sales, Revenue and Gross Margin (2021-2026)
4.6.4 NT Pharma Peramivir Product Portfolio
4.6.5 NT Pharma Recent Developments
4.7 SCOLR Pharma
4.7.1 SCOLR Pharma Company Information
4.7.2 SCOLR Pharma Business Overview
4.7.3 SCOLR Pharma Peramivir Sales, Revenue and Gross Margin (2021-2026)
4.7.4 SCOLR Pharma Peramivir Product Portfolio
4.7.5 SCOLR Pharma Recent Developments
4.8 Hunan Nucien Pharmaceutical Co., Ltd.
4.8.1 Hunan Nucien Pharmaceutical Co., Ltd. Company Information
4.8.2 Hunan Nucien Pharmaceutical Co., Ltd. Business Overview
4.8.3 Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales, Revenue and Gross Margin (2021-2026)
4.8.4 Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Product Portfolio
4.8.5 Hunan Nucien Pharmaceutical Co., Ltd. Recent Developments
4.9 Merck
4.9.1 Merck Company Information
4.9.2 Merck Business Overview
4.9.3 Merck Peramivir Sales, Revenue and Gross Margin (2021-2026)
4.9.4 Merck Peramivir Product Portfolio
4.9.5 Merck Recent Developments
4.10 Shionogi Co.
4.10.1 Shionogi Co. Company Information
4.10.2 Shionogi Co. Business Overview
4.10.3 Shionogi Co. Peramivir Sales, Revenue and Gross Margin (2021-2026)
4.10.4 Shionogi Co. Peramivir Product Portfolio
4.10.5 Shionogi Co. Recent Developments
5 Global Peramivir Market Scenario by Region
5.1 Global Peramivir Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Peramivir Sales by Region: 2021-2032
5.2.1 Global Peramivir Sales by Region: 2021-2026
5.2.2 Global Peramivir Sales by Region: 2027-2032
5.3 Global Peramivir Revenue by Region: 2021-2032
5.3.1 Global Peramivir Revenue by Region: 2021-2026
5.3.2 Global Peramivir Revenue by Region: 2027-2032
5.4 North America Peramivir Market Facts & Figures by Country
5.4.1 North America Peramivir Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Peramivir Sales by Country (2021-2032)
5.4.3 North America Peramivir Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.5 Europe Peramivir Market Facts & Figures by Country
5.5.1 Europe Peramivir Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Peramivir Sales by Country (2021-2032)
5.5.3 Europe Peramivir Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.6 Asia Pacific Peramivir Market Facts & Figures by Country
5.6.1 Asia Pacific Peramivir Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Peramivir Sales by Country (2021-2032)
5.6.3 Asia Pacific Peramivir Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 South America Peramivir Market Facts & Figures by Country
5.7.1 South America Peramivir Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Peramivir Sales by Country (2021-2032)
5.7.3 South America Peramivir Revenue by Country (2021-2032)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Peramivir Market Facts & Figures by Country
5.8.1 Middle East and Africa Peramivir Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Peramivir Sales by Country (2021-2032)
5.8.3 Middle East and Africa Peramivir Revenue by Country (2021-2032)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Peramivir Sales by Type (2021-2032)
6.1.1 Global Peramivir Sales by Type (2021-2032) & (Tons)
6.1.2 Global Peramivir Sales Market Share by Type (2021-2032)
6.2 Global Peramivir Revenue by Type (2021-2032)
6.2.1 Global Peramivir Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Peramivir Revenue Market Share by Type (2021-2032)
6.3 Global Peramivir Price by Type (2021-2032)
7 Segment by Application
7.1 Global Peramivir Sales by Application (2021-2032)
7.1.1 Global Peramivir Sales by Application (2021-2032) & (Tons)
7.1.2 Global Peramivir Sales Market Share by Application (2021-2032)
7.2 Global Peramivir Revenue by Application (2021-2032)
7.2.1 Global Peramivir Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Peramivir Revenue Market Share by Application (2021-2032)
7.3 Global Peramivir Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Peramivir Value Chain Analysis
8.1.1 Peramivir Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Peramivir Production Mode & Process
8.2 Peramivir Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Peramivir Distributors
8.2.3 Peramivir Customers
9 Global Peramivir Analyzing Market Dynamics
9.1 Peramivir Industry Trends
9.2 Peramivir Industry Drivers
9.3 Peramivir Industry Opportunities and Challenges
9.4 Peramivir Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Peramivir Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Peramivir Sales (Tons) of Manufacturers (2021-2026)
Table 7. Global Peramivir Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Peramivir Revenue of Manufacturers (2021-2026)
Table 9. Global Peramivir Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Peramivir Average Price (US$/Kg) of Manufacturers (2021-2026)
Table 11. Global Peramivir Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Peramivir, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Peramivir, Product Type & Application
Table 14. Global Peramivir Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Peramivir by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. BioCryst Pharmaceuticals Company Information
Table 19. BioCryst Pharmaceuticals Business Overview
Table 20. BioCryst Pharmaceuticals Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 21. BioCryst Pharmaceuticals Peramivir Product Portfolio
Table 22. BioCryst Pharmaceuticals Recent Developments
Table 23. Green Cross Pharma Company Information
Table 24. Green Cross Pharma Business Overview
Table 25. Green Cross Pharma Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 26. Green Cross Pharma Peramivir Product Portfolio
Table 27. Green Cross Pharma Recent Developments
Table 28. Hikma Pharmaceuticals Company Information
Table 29. Hikma Pharmaceuticals Business Overview
Table 30. Hikma Pharmaceuticals Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 31. Hikma Pharmaceuticals Peramivir Product Portfolio
Table 32. Hikma Pharmaceuticals Recent Developments
Table 33. Moksha8 Pharma Company Information
Table 34. Moksha8 Pharma Business Overview
Table 35. Moksha8 Pharma Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 36. Moksha8 Pharma Peramivir Product Portfolio
Table 37. Moksha8 Pharma Recent Developments
Table 38. NeoPharm Company Information
Table 39. NeoPharm Business Overview
Table 40. NeoPharm Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 41. NeoPharm Peramivir Product Portfolio
Table 42. NeoPharm Recent Developments
Table 43. NT Pharma Company Information
Table 44. NT Pharma Business Overview
Table 45. NT Pharma Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 46. NT Pharma Peramivir Product Portfolio
Table 47. NT Pharma Recent Developments
Table 48. SCOLR Pharma Company Information
Table 49. SCOLR Pharma Business Overview
Table 50. SCOLR Pharma Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 51. SCOLR Pharma Peramivir Product Portfolio
Table 52. SCOLR Pharma Recent Developments
Table 53. Hunan Nucien Pharmaceutical Co., Ltd. Company Information
Table 54. Hunan Nucien Pharmaceutical Co., Ltd. Business Overview
Table 55. Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 56. Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Product Portfolio
Table 57. Hunan Nucien Pharmaceutical Co., Ltd. Recent Developments
Table 58. Merck Company Information
Table 59. Merck Business Overview
Table 60. Merck Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 61. Merck Peramivir Product Portfolio
Table 62. Merck Recent Developments
Table 63. Shionogi Co. Company Information
Table 64. Shionogi Co. Business Overview
Table 65. Shionogi Co. Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 66. Shionogi Co. Peramivir Product Portfolio
Table 67. Shionogi Co. Recent Developments
Table 68. Global Peramivir Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 69. Global Peramivir Sales by Region (2021-2026) & (Tons)
Table 70. Global Peramivir Sales Market Share by Region (2021-2026)
Table 71. Global Peramivir Sales by Region (2027-2032) & (Tons)
Table 72. Global Peramivir Sales Market Share by Region (2027-2032)
Table 73. Global Peramivir Revenue by Region (2021-2026) & (US$ Million)
Table 74. Global Peramivir Revenue Market Share by Region (2021-2026)
Table 75. Global Peramivir Revenue by Region (2027-2032) & (US$ Million)
Table 76. Global Peramivir Revenue Market Share by Region (2027-2032)
Table 77. North America Peramivir Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 78. North America Peramivir Sales by Country (2021-2026) & (Tons)
Table 79. North America Peramivir Sales by Country (2027-2032) & (Tons)
Table 80. North America Peramivir Revenue by Country (2021-2026) & (US$ Million)
Table 81. North America Peramivir Revenue by Country (2027-2032) & (US$ Million)
Table 82. Europe Peramivir Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 83. Europe Peramivir Sales by Country (2021-2026) & (Tons)
Table 84. Europe Peramivir Sales by Country (2027-2032) & (Tons)
Table 85. Europe Peramivir Revenue by Country (2021-2026) & (US$ Million)
Table 86. Europe Peramivir Revenue by Country (2027-2032) & (US$ Million)
Table 87. Asia Pacific Peramivir Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 88. Asia Pacific Peramivir Sales by Country (2021-2026) & (Tons)
Table 89. Asia Pacific Peramivir Sales by Country (2027-2032) & (Tons)
Table 90. Asia Pacific Peramivir Revenue by Country (2021-2026) & (US$ Million)
Table 91. Asia Pacific Peramivir Revenue by Country (2027-2032) & (US$ Million)
Table 92. South America Peramivir Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 93. South America Peramivir Sales by Country (2021-2026) & (Tons)
Table 94. South America Peramivir Sales by Country (2027-2032) & (Tons)
Table 95. South America Peramivir Revenue by Country (2021-2026) & (US$ Million)
Table 96. South America Peramivir Revenue by Country (2027-2032) & (US$ Million)
Table 97. Middle East and Africa Peramivir Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 98. Middle East and Africa Peramivir Sales by Country (2021-2026) & (Tons)
Table 99. Middle East and Africa Peramivir Sales by Country (2027-2032) & (Tons)
Table 100. Middle East and Africa Peramivir Revenue by Country (2021-2026) & (US$ Million)
Table 101. Middle East and Africa Peramivir Revenue by Country (2027-2032) & (US$ Million)
Table 102. Global Peramivir Sales by Type (2021-2026) & (Tons)
Table 103. Global Peramivir Sales by Type (2027-2032) & (Tons)
Table 104. Global Peramivir Sales Market Share by Type (2021-2026)
Table 105. Global Peramivir Sales Market Share by Type (2027-2032)
Table 106. Global Peramivir Revenue by Type (2021-2026) & (US$ Million)
Table 107. Global Peramivir Revenue by Type (2027-2032) & (US$ Million)
Table 108. Global Peramivir Revenue Market Share by Type (2021-2026)
Table 109. Global Peramivir Revenue Market Share by Type (2027-2032)
Table 110. Global Peramivir Price by Type (2021-2026) & (US$/Kg)
Table 111. Global Peramivir Price by Type (2027-2032) & (US$/Kg)
Table 112. Global Peramivir Sales by Application (2021-2026) & (Tons)
Table 113. Global Peramivir Sales by Application (2027-2032) & (Tons)
Table 114. Global Peramivir Sales Market Share by Application (2021-2026)
Table 115. Global Peramivir Sales Market Share by Application (2027-2032)
Table 116. Global Peramivir Revenue by Application (2021-2026) & (US$ Million)
Table 117. Global Peramivir Revenue by Application (2027-2032) & (US$ Million)
Table 118. Global Peramivir Revenue Market Share by Application (2021-2026)
Table 119. Global Peramivir Revenue Market Share by Application (2027-2032)
Table 120. Global Peramivir Price by Application (2021-2026) & (US$/Kg)
Table 121. Global Peramivir Price by Application (2027-2032) & (US$/Kg)
Table 122. Key Raw Materials
Table 123. Raw Materials Key Suppliers
Table 124. Peramivir Distributors List
Table 125. Peramivir Customers List
Table 126. Peramivir Industry Trends
Table 127. Peramivir Industry Drivers
Table 128. Peramivir Industry Restraints
Table 129. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Peramivir Product Image
Figure 5. Global Peramivir Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Peramivir Market Size (2021-2032) & (US$ Million)
Figure 7. Global Peramivir Sales (2021-2032) & (Tons)
Figure 8. Global Peramivir Average Price (US$/Kg) & (2021-2032)
Figure 9. Solution Product Image
Figure 10. Solid Product Image
Figure 11. Influenza A Treatment Product Image
Figure 12. Influenza B Treatment Product Image
Figure 13. Global Peramivir Revenue Share by Manufacturers in 2025
Figure 14. Global Manufacturers of Peramivir, Manufacturing Sites & Headquarters
Figure 15. Global Top 5 and 10 Peramivir Players Market Share by Revenue in 2025
Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 17. Global Peramivir Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 18. Global Peramivir Sales by Region in 2025
Figure 19. Global Peramivir Revenue by Region in 2025
Figure 20. North America Peramivir Market Size by Country in 2025
Figure 21. North America Peramivir Sales Market Share by Country (2021-2032)
Figure 22. North America Peramivir Revenue Market Share by Country (2021-2032)
Figure 23. United States Peramivir Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 24. Canada Peramivir Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 25. Europe Peramivir Market Size by Country in 2025
Figure 26. Europe Peramivir Sales Market Share by Country (2021-2032)
Figure 27. Europe Peramivir Revenue Market Share by Country (2021-2032)
Figure 28. Germany Peramivir Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 29. France Peramivir Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 30. U.K. Peramivir Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. Italy Peramivir Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. Netherlands Peramivir Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. Asia Pacific Peramivir Market Size by Country in 2025
Figure 34. Asia Pacific Peramivir Sales Market Share by Country (2021-2032)
Figure 35. Asia Pacific Peramivir Revenue Market Share by Country (2021-2032)
Figure 36. China Peramivir Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Japan Peramivir Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. South Korea Peramivir Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. India Peramivir Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Australia Peramivir Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. China Taiwan Peramivir Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. Southeast Asia Peramivir Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 43. Southeast Asia Peramivir Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. South America Peramivir Market Size by Country in 2025
Figure 45. South America Peramivir Sales Market Share by Country (2021-2032)
Figure 46. South America Peramivir Revenue Market Share by Country (2021-2032)
Figure 47. Mexico Peramivir Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. Brazil Peramivir Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Argentina Peramivir Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Middle East and Africa Peramivir Market Size by Country in 2025
Figure 51. Middle East and Africa Peramivir Sales Market Share by Country (2021-2032)
Figure 52. Middle East and Africa Peramivir Revenue Market Share by Country (2021-2032)
Figure 53. Turkey Peramivir Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 54. Saudi Arabia Peramivir Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 55. UAE Peramivir Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Global Peramivir Sales Market Share by Type (2021-2032)
Figure 57. Global Peramivir Revenue Market Share by Type (2021-2032)
Figure 58. Global Peramivir Price (US$/Kg) by Type (2021-2032)
Figure 59. Global Peramivir Sales Market Share by Application (2021-2032)
Figure 60. Global Peramivir Revenue Market Share by Application (2021-2032)
Figure 61. Global Peramivir Price (US$/Kg) by Application (2021-2032)
Figure 62. Peramivir Value Chain
Figure 63. Peramivir Production Mode & Process
Figure 64. Direct Comparison with Distribution Share
Figure 65. Distributors Profiles
Figure 66. Peramivir Industry Opportunities and Challenges
提及公司
BioCryst PharmaceuticalsGreen Cross PharmaHikma PharmaceuticalsMoksha8 PharmaNeoPharmNT PharmaSCOLR PharmaHunan Nucien Pharmaceutical Co., Ltd.MerckShionogi Co.
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們